Skip to Content
Søk Menu

The SPARTAN study – the treatment of non-metastatic castration-resistant prostate cancer

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Relateret indhold

Implementation of Early Specialized Palliative Care in an Oncologic Department

/ Katrine Rahbek Schønnemann / Sabine Ute Alice Gill
Kreft
Marc Eid og Karl Semaan

Cancer Epigenomics Improve the Overall Survival and the Quality of Life

/ Marc Eid / Karl Semaan
ASCOGU24Prostatakreft Play the Video 1:31

ASCO GU 2024: A Combination of Cabozantinib and Atezolizumab is Promising for Advanced Prostate Cancer Patients with Poor Prognoses

/ Sofie Pohl
ASCOGU24Prostatakreft
Maha H. A. Hussain

Data from the BRCAAway Study Confirms Better PFS & Efficacy with a Combination of Olaparib + Abiraterone Prednisone

/ Maha H. A. Hussain
ASCOGU24Prostatakreft Play the Video 03:10
Neeraj Agarwal

CONTACT-2: Cabozantinib + Atezolizumab for Patients with Metastatic Castration-Resistant Prostate Cancer

/ Neeraj Agarwal
ASCOGU24Prostatakreft Play the Video 05:04
Petter Brandal

Insights from Onkologisk Forum 2023

/ Petter Brandal
KreftOnkologiskForum23 Play the Video 5:16
Bettina Kulle Andreassen

The Value of Real-World Data in Clinical Oncological Research

/ Bettina Kulle Andreassen
KreftOnkologiskForum23 Play the Video 3:02
Petter Brandal

Proton vs Photon Radiotherapy for Brain Tumors in Patients with Diffuse Grade 2 and 3 Gliomas

/ Petter Brandal
KreftOnkologiskForum23 Play the Video 3:02
Kenneth Jensen

Proton Therapy for Head and Neck Cancer

/ Kenneth Jensen
KreftOnkologiskForum23 Play the Video 4:11
Back to top